NGNE·64135M105·US·equity·Healthcare - Biotechnology-13D/G
NGNE (NEUROGENE INC) is held by 62 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($27.5M), BlackRock, Inc. ($20.3M), BAKER BROS. ADVISORS LP ($20M). Net institutional sentiment: Mixed.
See how NGNE's score breaks down across 4 SEC sources
Showing 1-20 of 69
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer